Genotoxic biomarkers in patients on hemodialiasis

Natalia V. Eremina , Andrey D. Durnev

Ecological Genetics ›› 2020, Vol. 18 ›› Issue (3) : 367 -389.

PDF (283KB)
Ecological Genetics ›› 2020, Vol. 18 ›› Issue (3) : 367 -389. DOI: 10.17816/ecogen26281
Genetic toxicology
research-article

Genotoxic biomarkers in patients on hemodialiasis

Author information +
History +
PDF (283KB)

Abstract

It is generally recognized that genotoxic damage have essential etiopathogenetic significance, and its prevention is an important measure to preserve human life and health. In the framework of this concept, literature information on studies of genotoxic biomarkers in patients with various hemodialysis regiments has been reviewed and summarized, and ways to prevent detectable genotoxicity have been identified. Based on the analysis of the known data, it was concluded that patients of this group have an increased level of DNA and chromosome damage in peripheral blood lymphocytes. Based on the results of individual studies, it was shown that one of the strategies for reducing genotoxicity may be the improvement of hemodialysis therapy methods and regimes, as well as pharmacological and nutritional correction of genotoxic effects.

Keywords

hemodialysis / hemodiafiltration / genotoxicity / DNA damage / chromosomal aberrations / micronuclei

Cite this article

Download citation ▾
Natalia V. Eremina,Andrey D. Durnev. Genotoxic biomarkers in patients on hemodialiasis. Ecological Genetics, 2020, 18(3): 367-389 DOI:10.17816/ecogen26281

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

Eremina N.V., Durnev A.D.

AI Summary AI Mindmap
PDF (283KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/